Category: Specific Treatments

Specific Treatments

5-ASA

Mesalamine

Steroids

Budesonide

Infliximab

Remicade

Adalimumab

Humira

Thiopurines

Imuran, 6-MP

Vedolizumab

Entyvio

Ustekinumab

Stelara

Tofacitinib

Xeljanz

Email Newsletter

Recent News

Lipitor reduces colectomy rate in ulcerative colitis
September 16, 2021
AGA publishes practice update for management of colorectal dysplasia in IBD
September 14, 2021
7 Recent reports on IBD
September 11, 2021
VIDEO: Increased visceral adipose tissue links to decreased IBD remission
September 10, 2021
Corticosteroids decrease COVID-19 vaccine efficacy in IBD
September 3, 2021
Cholesterol levels increase after corticosteroid, tofacitinib use in IBD
September 1, 2021
Macrolides, fluoroquinolones reduce risk for anti-drug antibodies in IBD treatment
August 9, 2021
New GI symptoms do not link to increased risk for death in IBD, COVID-19
August 3, 2021
Adalimumab may be efficacious, safe treatment for children with ulcerative colitis
July 29, 2021
Obesity does not increase risk for serious infection in biologic-treated IBD
July 28, 2021